CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders
Summary
Wellgistics Health released a letter to shareholders explaining how a series of recent transactions form a unified strategy to build vertically integrated, blockchain-backed healthcare infrastructure. The company plans to integrate its EinsteinRx AI pharmacy dispensing platform with its PharmacyChain blockchain, expand the Datavault license, form DelivMeds AI, acquire QOLPOM biometric IP, and take a controlling interest in Tollo Health to extend patient-facing services. Wellgistics highlights its connectivity to more than 6,500 pharmacies and 200+ manufacturers and says the moves aim to turn fragmented health data into verifiable, tokenized assets. The letter also notes a planned share restructuring, targeted product and program milestones (including an August 2026 app launch), and standard regulatory and execution risks as agreements are finalized.
